Loading...
Next Day DeliveryRegistered Pharmacy100% OnlineFully Inspected & Regulated ServicesApproved UK-licensed TreatmentsNext Day DeliveryRegistered Pharmacy100% OnlineFully Inspected & Regulated ServicesApproved UK-licensed Treatments
Nayan Shah
Pharmacy Director
Our clinicians listen, guide, and help you make confident choices about your health at your pace. Every assessment is private, judgment-free, and reviewed by a qualified prescriber.
Wegovy pill contain semaglutide, a prescription-only medicine used for weight management in eligible adults. Taken once daily alongside a reduced-calorie diet and increased physical activity, Wegovy works on the GLP-1 pathway involved in appetite regulation.Once-daily oral pillContains semaglutide, a GLP-1 medicineAvailable in 1.5 mg, 4 mg, 9 mg and 25 mg strengthsTreatment begins at a lower dose and is increased gradually under clinical guidanceUsed alongside a reduced-calorie diet and increased physical activityPrescription-only and subject to clinician assessmentFor eligible adults aged 18 and overThe MHRA authorised Wegovy Pill for weight management in the UK on 11 June 2026. The approved strengths are 1.5 mg, 4 mg, 9 mg and 25 mg.Coming soonWegovy Pill availability through LYV is expected from 6 July 2026. Register your interest to receive an update when treatment becomes available.Availability is subject to confirmed stock, completion of a clinical assessment and approval by a qualified prescriber.
£99.00
Wegovy pill contain semaglutide, a prescription-only medicine used for weight management in eligible adults. Taken once daily alongside a reduced-calorie diet and increased physical activity, Wegovy works on the GLP-1 pathway involved in appetite regulation.Once-daily oral pillContains semaglutide, a GLP-1 medicineAvailable in 1.5 mg, 4 mg, 9 mg and 25 mg strengthsTreatment begins at a lower dose and is increased gradually under clinical guidanceUsed alongside a reduced-calorie diet and increased physical activityPrescription-only and subject to clinician assessmentFor eligible adults aged 18 and overThe MHRA authorised Wegovy Pill for weight management in the UK on 11 June 2026. The approved strengths are 1.5 mg, 4 mg, 9 mg and 25 mg.Coming soonWegovy Pill availability through LYV is expected from 6 July 2026. Register your interest to receive an update when treatment becomes available.Availability is subject to confirmed stock, completion of a clinical assessment and approval by a qualified prescriber.
£109.00
Wegovy pill contain semaglutide, a prescription-only medicine used for weight management in eligible adults. Taken once daily alongside a reduced-calorie diet and increased physical activity, Wegovy works on the GLP-1 pathway involved in appetite regulation.Once-daily oral pillContains semaglutide, a GLP-1 medicineAvailable in 1.5 mg, 4 mg, 9 mg and 25 mg strengthsTreatment begins at a lower dose and is increased gradually under clinical guidanceUsed alongside a reduced-calorie diet and increased physical activityPrescription-only and subject to clinician assessmentFor eligible adults aged 18 and overThe MHRA authorised Wegovy Pill for weight management in the UK on 11 June 2026. The approved strengths are 1.5 mg, 4 mg, 9 mg and 25 mg.Coming soonWegovy Pill availability through LYV is expected from 6 July 2026. Register your interest to receive an update when treatment becomes available.Availability is subject to confirmed stock, completion of a clinical assessment and approval by a qualified prescriber.
£129.00
This product will be available on July 21, 2026.
Wegovy pill contain semaglutide, a prescription-only medicine used for weight management in eligible adults. Taken once daily alongside a reduced-calorie diet and increased physical activity, Wegovy works on the GLP-1 pathway involved in appetite regulation.Once-daily oral pillContains semaglutide, a GLP-1 medicineAvailable in 1.5 mg, 4 mg, 9 mg and 25 mg strengthsTreatment begins at a lower dose and is increased gradually under clinical guidanceUsed alongside a reduced-calorie diet and increased physical activityPrescription-only and subject to clinician assessmentFor eligible adults aged 18 and overThe MHRA authorised Wegovy Pill for weight management in the UK on 11 June 2026. The approved strengths are 1.5 mg, 4 mg, 9 mg and 25 mg.Coming soonWegovy Pill availability through LYV is expected from 6 July 2026. Register your interest to receive an update when treatment becomes available.Availability is subject to confirmed stock, completion of a clinical assessment and approval by a qualified prescriber.
£187.00
This product will be available on July 21, 2026.
-2.png&w=1440&q=75)
Wegovy is a prescription-only once-weekly injection used alongside a reduced-calorie diet and increased physical activity to support weight loss and weight maintenance in eligible adults with obesity or overweight with weight-related health conditions.Once-weekly prefilled pen for injection under the skin of the abdomen, thigh or upper armTreatment starts at 0.25 mg once weekly, increasing gradually over 16 weeks to a maintenance dose, under clinician supervisionUse on the same day each week. Missed dose guidance appliesSuitable for adults with BMI 30+ or BMI 27+ or above with weight-related health conditions, subject to clinical assessmentContinued treatment requires regular medical review and evidence of clinical benefitSAFETY INFORMATION
£98.00
-3.png&w=1440&q=75)
Wegovy is a prescription-only once-weekly injection used alongside a reduced-calorie diet and increased physical activity to support weight loss and weight maintenance in eligible adults with obesity or overweight with weight-related health conditions.Once-weekly prefilled pen for injection under the skin of the abdomen, thigh or upper armTreatment starts at 0.25 mg once weekly, increasing gradually over 16 weeks to a maintenance dose, under clinician supervisionUse on the same day each week. Missed dose guidance appliesSuitable for adults with BMI 30+ or BMI 27+ or above with weight-related health conditions, subject to clinical assessmentContinued treatment requires regular medical review and evidence of clinical benefitSAFETY INFORMATION
£117.81
-5.png&w=1440&q=75)
Wegovy is a prescription-only once-weekly injection used alongside a reduced-calorie diet and increased physical activity to support weight loss and weight maintenance in eligible adults with obesity or overweight with weight-related health conditions.Once-weekly prefilled pen for injection under the skin of the abdomen, thigh or upper armTreatment starts at 0.25 mg once weekly, increasing gradually over 16 weeks to a maintenance dose, under clinician supervisionUse on the same day each week. Missed dose guidance appliesSuitable for adults with BMI 30+ or BMI 27+ or above with weight-related health conditions, subject to clinical assessmentContinued treatment requires regular medical review and evidence of clinical benefitSAFETY INFORMATION
£123.74
-4.png&w=1440&q=75)
Wegovy is a prescription-only once-weekly injection used alongside a reduced-calorie diet and increased physical activity to support weight loss and weight maintenance in eligible adults with obesity or overweight with weight-related health conditions.Once-weekly prefilled pen for injection under the skin of the abdomen, thigh or upper armTreatment starts at 0.25 mg once weekly, increasing gradually over 16 weeks to a maintenance dose, under clinician supervisionUse on the same day each week. Missed dose guidance appliesSuitable for adults with BMI 30+ or BMI 27+ or above with weight-related health conditions, subject to clinical assessmentContinued treatment requires regular medical review and evidence of clinical benefitSAFETY INFORMATION
£167.30
-1.png&w=1440&q=75)
Wegovy is a prescription-only once-weekly injection used alongside a reduced-calorie diet and increased physical activity to support weight loss and weight maintenance in eligible adults with obesity or overweight with weight-related health conditions.Once-weekly prefilled pen for injection under the skin of the abdomen, thigh or upper armTreatment starts at 0.25 mg once weekly, increasing gradually over 16 weeks to a maintenance dose, under clinician supervisionUse on the same day each week. Missed dose guidance appliesSuitable for adults with BMI 30+ or BMI 27+ or above with weight-related health conditions, subject to clinical assessmentContinued treatment requires regular medical review and evidence of clinical benefitSAFETY INFORMATION
£216.80
Mounjaro is a prescription-only once-weekly injection used alongside a reduced-calorie diet and increased physical activity for the treatment of type 2 diabetes and for weight management, including weight loss and weight maintenance, in eligible adults.Once-weekly pre-filled injection pen for use in the abdomen, thigh, or upper armWorks by activating both GLP-1 and GIP receptors to help regulate appetite and blood sugar levelsTreatment usually starts at 2.5 mg once weekly and may be increased gradually under clinical supervision up to a maximum of 15 mgSuitable for adults with BMI 30+ or BMI 27+ with weight-related health conditions, subject to clinician assessmentContinued treatment requires regular medical review and dose adjustmentNot suitable for anyone under 18Prescription supplied only following approval by a licensed clinicianSAFETY INFORMATION
£163.34
Mounjaro is a prescription-only once-weekly injection used alongside a reduced-calorie diet and increased physical activity for the treatment of type 2 diabetes and for weight management, including weight loss and weight maintenance, in eligible adults.Once-weekly pre-filled injection pen for use in the abdomen, thigh, or upper armWorks by activating both GLP-1 and GIP receptors to help regulate appetite and blood sugar levelsTreatment usually starts at 2.5 mg once weekly and may be increased gradually under clinical supervision up to a maximum of 15 mgSuitable for adults with BMI 30+ or BMI 27+ with weight-related health conditions, subject to clinician assessmentContinued treatment requires regular medical review and dose adjustmentNot suitable for anyone under 18Prescription supplied only following approval by a licensed clinicianSAFETY INFORMATION
£173.24
Mounjaro is a prescription-only once-weekly injection used alongside a reduced-calorie diet and increased physical activity for the treatment of type 2 diabetes and for weight management, including weight loss and weight maintenance, in eligible adults.Once-weekly pre-filled injection pen for use in the abdomen, thigh, or upper armWorks by activating both GLP-1 and GIP receptors to help regulate appetite and blood sugar levelsTreatment usually starts at 2.5 mg once weekly and may be increased gradually under clinical supervision up to a maximum of 15 mgSuitable for adults with BMI 30+ or BMI 27+ with weight-related health conditions, subject to clinician assessmentContinued treatment requires regular medical review and dose adjustmentNot suitable for anyone under 18Prescription supplied only following approval by a licensed clinicianSAFETY INFORMATION
£232.64
Mounjaro is a prescription-only once-weekly injection used alongside a reduced-calorie diet and increased physical activity for the treatment of type 2 diabetes and for weight management, including weight loss and weight maintenance, in eligible adults.Once-weekly pre-filled injection pen for use in the abdomen, thigh, or upper armWorks by activating both GLP-1 and GIP receptors to help regulate appetite and blood sugar levelsTreatment usually starts at 2.5 mg once weekly and may be increased gradually under clinical supervision up to a maximum of 15 mgSuitable for adults with BMI 30+ or BMI 27+ with weight-related health conditions, subject to clinician assessmentContinued treatment requires regular medical review and dose adjustmentNot suitable for anyone under 18Prescription supplied only following approval by a licensed clinicianSAFETY INFORMATION
£257.39
Mounjaro is a prescription-only once-weekly injection used alongside a reduced-calorie diet and increased physical activity for the treatment of type 2 diabetes and for weight management, including weight loss and weight maintenance, in eligible adults.Once-weekly pre-filled injection pen for use in the abdomen, thigh, or upper armWorks by activating both GLP-1 and GIP receptors to help regulate appetite and blood sugar levelsTreatment usually starts at 2.5 mg once weekly and may be increased gradually under clinical supervision up to a maximum of 15 mgSuitable for adults with BMI 30+ or BMI 27+ with weight-related health conditions, subject to clinician assessmentContinued treatment requires regular medical review and dose adjustmentNot suitable for anyone under 18Prescription supplied only following approval by a licensed clinicianSAFETY INFORMATION
£272.24
Mounjaro is a prescription-only once-weekly injection used alongside a reduced-calorie diet and increased physical activity for the treatment of type 2 diabetes and for weight management, including weight loss and weight maintenance, in eligible adults.Once-weekly pre-filled injection pen for use in the abdomen, thigh, or upper armWorks by activating both GLP-1 and GIP receptors to help regulate appetite and blood sugar levelsTreatment usually starts at 2.5 mg once weekly and may be increased gradually under clinical supervision up to a maximum of 15 mgSuitable for adults with BMI 30+ or BMI 27+ with weight-related health conditions, subject to clinician assessmentContinued treatment requires regular medical review and dose adjustmentNot suitable for anyone under 18Prescription supplied only following approval by a licensed clinicianSAFETY INFORMATION
£292.04
